Management of chronic myeloid leukaemia

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

European heart journal·2026

Related Experiment Videos

Management of chronic myeloid leukaemia

Related Concept Videos

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans.

Phenotype and progeny of primitive adherent human hematopoietic progenitors.

Expression of the LH2 gene in chronic myeloid leukaemia cells.

Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: the risk in misinterpreting negative results.

Rarity of microsatellite alterations in acute myeloid leukaemia.

Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).

The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.

RES phagocytosis in children with homozygous beta-thalassemia in relation to blood transfusion.

Two allotypes of factor IX present in haemophilia B.

Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients.

Prognostic significance of a morphometric study of lymph node biopsies in chronic lymphocytic leukaemia.

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

Related Experiment Videos

Management of chronic myeloid leukaemia

Related Concept Videos

Related Articles